The recent Ebola virus disease outbreak in West Africa has increased the need for U.S. healthcare facilities to be prepared to safely manage a patient with suspected Ebola virus disease. Mark your calendars for a joint webinar on Ebola preparations with CDC and the Association for Professionals in Infection Control and Epidemiology (APIC) on Wednesday, Aug. 13, 2014, at 1 p.m. EDT.
Answering questions will be CDC’s Dr. David Kuhar, healthcare and worker safety team lead for the CDC Ebola response; Dr. Barbara Knust, epidemiology team Lead for the CDC Ebola response; and Dr. Tim Uyeki, clinical team lead for the CDC Ebola response. Speakers will address infection preventionists' questions on steps U.S. healthcare facilities can take to prepare for the possibility of caring for a patient with Ebola virus disease.
To register for "What Infection Preventionists need to know about Ebola Preparations," visit APIC’s website.
Source: CDC
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.